FDA.reportPublic FDA data

Application 209512

Type
NDA
Sponsor
ABBVIE INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001NORVIRRITONAVIRPOWDER;ORAL100MG/PACKETYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0074-3399NorvirRitonavirAbbVie Inc.NDACurrent
0074-3399NorvirRitonavirAbbVie Inc.NDACurrent
0074-3399NorvirRitonavirAbbVie Inc.NDACurrent
0074-3399NorvirRitonavirAbbVie Inc.NDACurrent
0074-3399NorvirRitonavirAbbVie Inc.NDACurrent
0074-3399NorvirRitonavirAbbVie Inc.NDACurrent
0074-3399NorvirRitonavirAbbVie Inc.NDACurrent
0074-3399NorvirRitonavirAbbVie Inc.NDACurrent
0074-3399NorvirRitonavirAbbVie Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
72960SUPPL2022-12-20
72918SUPPL2022-12-16
65024SUPPL2020-10-23
64975SUPPL2020-10-22
61484SUPPL2019-12-31
61379SUPPL2019-12-23
59816SUPPL2019-08-22
59805SUPPL2019-08-22
56683SUPPL2018-12-07
56542SUPPL2018-11-23
52958ORIG2018-03-14
52853ORIG2018-03-08
49926SUPPL2017-10-03
49919SUPPL2017-10-03
48886SUPPL2017-06-30
48878SUPPL2017-06-30
48671ORIG2017-06-08